SCHEMBL4580268

SCHEMBL4580268

Clc1nccc(N2CCCCC2c2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 3/20 0.46
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
CDC42BPB Q9Y5S2 1/20 0.41
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
IDH1 O75874 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC8 Q9BY41 1/20 0.38
GPR39 O43194 1/20 0.38
DYRK1A Q13627 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30748784 0.89 NUDT1 (0.38) NUDT1ROCK2ROCK1CDC42BPBIDH1
SCHEMBL4580389 0.80 NUDT1 (0.48) NUDT1ROCK2ROCK1CDC42BPBIDH1
SCHEMBL4581477 0.79 NR3C2 (0.54) NUDT1IDH1HDAC6HDAC8PIK3C3
SCHEMBL4581475 0.79 NR3C2 (0.54) NUDT1IDH1HDAC6HDAC8PIK3C3
SCHEMBL4581446 0.78 IDH1 (0.57) NUDT1IDH1ALDH1A1MEN1KMT2A
SCHEMBL12185048 0.77 BCHE (0.43) DYRK1AALDH1A1KDM4EMAPTHTT
SCHEMBL12615103 0.77 BCHE (0.43) DYRK1AALDH1A1KDM4EMAPTHTT
SCHEMBL20575880 0.76 PRCP (0.42) NUDT1PSEN1PSEN2APH1BNCSTN
SCHEMBL30749076 0.74 SORD (0.46)
SCHEMBL2640795 0.74 HPGD (0.42) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323464-B2 Pyridine and pyrimidine derivatives CELLTECH R&D LIMITED (GB) 2008-01-29 US disclosed
US-20050080258-A1 Pyridine and pyrimidine derivatives GENTEX CORPORATION 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080258-A1 Pyridine and pyrimidine derivatives ROR1, MAPK1, IRAK1 NUDT1 762/4885ROCK2 1139/4885ROCK1 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.